TrialJournal of child and adolescent psychopharmacology2021

A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Clinical Trial of ORADUR-Methylphenidate for Treating Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.

Yu-Shu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.